Hydrogen Sulfide: An Emerging Precision Strategy for Gas Therapy.

Ding, He; Chang, Jinhu; He, Fei; Gai, Shili; Yang, Piaoping · Adv Healthc Mater · 2022

review · Level V

Where this comes from

Abstract

Advances in nanotechnology have enabled the rapid development of stimuli-responsive therapeutic nanomaterials for precision gas therapy. Hydrogen sulfide (H<sub>2</sub> S) is a significant gaseous signaling molecule with intrinsic biochemical properties, which exerts its various physiological effects under both normal and pathological conditions. Various nanomaterials with H<sub>2</sub> S-responsive properties, as new-generation therapeutic agents, are explored to guide therapeutic behaviors in biological milieu. The cross disciplinary of H<sub>2</sub> S is an emerging scientific hotspot that studies the chemical properties, biological mechanisms, and therapeutic effects of H<sub>2</sub> S. This review summarizes the state-of-art research on H<sub>2</sub> S-related nanomedicines. In particular, recent advances in H<sub>2</sub> S therapeutics for cancer, such as H<sub>2</sub> S-mediated gas therapy and H<sub>2</sub> S-related synergistic therapies (combined with chemotherapy, photodynamic therapy, photothermal therapy, and chemodynamic therapy) are highlighted. Versatile imaging techniques for real-time monitoring H<sub>2</sub> S during biological diagnosis are reviewed. Finally, the biosafety issues, current challenges, and potential possibilities in the evolution of H<sub>2</sub> S-based therapy that facilitate clinical translation to patients are discussed.

Medical subject headings